ALLMedicine™ Fatigue Center

Mar 28th, 2023 - Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell death 1 receptor. The combination of chemotherapy and immunotherapy may have synergistic effects in the treatment of endometrial cancer. We conducted a phase 3, global,...

Mar 28th, 2023 - Imatinib mesylate (IM) is the standard chemotherapy for patients with gastrointestinal stromal tumors (GISTs) and has a favorable safety profile. Pharmacokinetics (PK), such as plasma trough concentration (Cmin), varies among patients, requiring t...

Mar 28th, 2023 - Symptom burden in adolescents and young adults (AYA) with cancer is poorly characterized but impacts quality of life. All Ontario, Canada AYA aged 15-29 years at diagnosis between 2010 and 2018 were linked to population-based healthcare databases,...

Mar 28th, 2023 - Adults are recommended to engage in moderate-vigorous physical activity (MVPA) to maintain health. But including exercise sessions within a day inevitably requires reallocating time from other physical behavior(s): sleep, sedentary behavior, or ph...

Mar 27th, 2023 - There is growing concern that Coronavirus Disease 2019 (COVID-19) vaccine fatigue will be a major obstacle in maintaining immunity in the general population. In this study, we assessed vaccine acceptance in future scenarios in two conjoint experim...

Mar 27th, 2023 - There is growing concern that Coronavirus Disease 2019 (COVID-19) vaccine fatigue will be a major obstacle in maintaining immunity in the general population. In this study, we assessed vaccine acceptance in future scenarios in two conjoint experim...

Mar 24th, 2023 - Heart failure with preserved ejection fraction (HFpEF) is one of the most common forms of heart failure; its prevalence is increasing, and outcomes are worsening. Affected patients often experience severe exertional dyspnea and debilitating fatigu...

Mar 23rd, 2023 - What do I need to know about Long-Covid-related Fatigue, Brain Fog, and Mental Health Changes?|2023|Gross M,Lansang NM,Gopaul U,Ogawa EF,Heyn PC,|

Jan 27th, 2023 - Most research on SARS-CoV-2 variants focuses on initial symptomatology with limited data on longer-term sequelae. We sought to characterize the prevalence and differences in prolonged symptoms at three months post SARS-CoV-2-infection across the t...

Dec 1st, 2022 - Post–COVID-19 conditions (PCCs), often referred to as long COVID, are a heterogeneous group of conditions generally referring to symptoms that emerge, recur, or persist for more than 4 weeks after acute infection with SARS-CoV-2.1 Hallmarks of PCC...

Mar 27th, 2023 - There is growing concern that Coronavirus Disease 2019 (COVID-19) vaccine fatigue will be a major obstacle in maintaining immunity in the general population. In this study, we assessed vaccine acceptance in future scenarios in two conjoint experim...

Mar 24th, 2023 - This is a prospective, interventional pilot study that plans to enroll 15 patients who are receiving salvage high dose chemo and bone marrow transplant for relapsed Germ cell Cancer (rGCC). Patients will be asked to go through a series of surveys ...

Mar 23rd, 2023 - Fatigue due to cancer and its treatment (for example, radiation therapy) can interfere with quality of life and can linger long after treatment has ended, yet research examining preventative approaches has produced limited clinical benefit. The pr...

Mar 23rd, 2023 - PRIMARY OBJECTIVE: I. To compare overall survival (OS) for patients with LS-SCLC treated with chemoradiation +/- atezolizumab. SECONDARY OBJECTIVES: I. To compare progression free survival (PFS) for patients with limited stage small cell lung canc...

Mar 22nd, 2023 - This study will evaluate the ability of four aromatherapy scents (ginger, lavender, orange, jojoba) to reduce the severity of seven chemotherapy-induced symptoms (nausea, vomiting, pain, anxiety/distress, fatigue, sleep difficulties, and lack of a...

Mar 28th, 2023 - Two groups of long COVID patients -- those hospitalized for acute COVID, and those with mild SARS-CoV-2 infection who weren't hospitalized -- had different neurologic manifestations, prospective data showed. Long COVID patients who were hospitaliz...

Mar 27th, 2023 - There is growing concern that Coronavirus Disease 2019 (COVID-19) vaccine fatigue will be a major obstacle in maintaining immunity in the general population. In this study, we assessed vaccine acceptance in future scenarios in two conjoint experim...

Mar 24th, 2023 - Patients with functional neurologic disorder (FND) after SARS-CoV-2 infection had different symptoms than people with FND after COVID vaccines, retrospective data showed. Patients with post-COVID FND tended to be older, had more insidious onset, a...

Mar 22nd, 2023 - The second time proved to be the charm for the PD-1 inhibitor retifanlimab (Zynyz), as the FDA approved the drug for Merkel cell carcinoma (MCC). The agency had previously rejected an application from Incyte for approval of retifanlimab for locall...

Mar 20th, 2023 - The history and findings in this case are suggestive of non–small cell lung cancer (NSCLC) large cell carcinoma. Lung cancer is the most common cancer worldwide and has the highest mortality rate of all cancers.